Select country change
Shopping cart (0 , 0,00 ) Menu Search
Distributed product

Positive control: Humanized IgG Monoclonal Antibody against SARS-CoV-2 Nucleocapsid Protein (NP)

  • Regulatory status:RUO
  • Type:Control Set
  • Other names:Severe acute respiratory syndrome coronavirus 2 nucleocapsid, 2019 novel coronavirus nucleoprotein, SARS-CoV-2 NP, SARS-CoV-2 N protein, COVID-19
  • Species:Human
Please select your region to see available products and prices.
Cat. No. Size Price

New 41A227 220 μl per vial
PubMed Product Details
Technical Data


Control Set


Ready-to-use positive control for SARS-CoV-2 NP IgG ELISA 50µl per ELISA test


Add 110 μl deionized water into each tube and let the lyophilized pellet dissolve completely.



Sample Requirements

50 μl/well


Store the lyophilized antibody at -20°C for long-term storage. After reconstitution, store at 4 degrees for short-term storage (3 days) or store in aliquots at -80 degrees for long-term storage. Avoid frequent freeze-thaw cycles.



  • This product is intended for research use only.
  • After reconstitution, it is ready-to-use positive control for SARS-CoV-2 NP IgG ELISA.

Research topic



Since December 2019, outbreak of SARS-CoV-2 (COVID-19) infection has become a major epidemic threat in China and brought back the attention of pathogenic coronavirus to the spotlight. Nucleocapsid protein (NP) is the most abundant protein on the helical nucleocapsid of coronaviruses, which envelopes the entire genomic RNA. NP also interacts with other viron structural proteins to play important roles during host cell entry and virus particle assembly and release. Anti-NP antibodies have been shown to be the earliest and the most predominant antibodies detectable in patient’s blood samples after coronavirus infection. Human anti-COVID-19 nucleocapsid protein (NP) IgG ELISA kit is a highly sensitive and specific ELISA kit for the precision detection and quantitative measurement of titres of anti-NP IgG class antibodies in human serum.

Related Products Docs